참고문헌
- Alvarez A, Moncayo Ji, Santacruz Jj, et al (2009). Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia. Antimicrobial Agents Chemotherapy, 53, 4022-4. https://doi.org/10.1128/AAC.00145-09
- Baglan Ph, Bozdayi G, Ozkan M, et al (2006). Clarithromycin resistance prevalence and iceA gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J Microbiol-Seoul, 44, 409.
-
Bazargani A, Khoramrooz Ss, Kamali-Sarvestani E, et al (2010). Association between peroxisome proliferator-activated receptor-
${\gamma}$ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis. Scandinavian J gastroenterol, 45, 1162-7. https://doi.org/10.3109/00365521.2010.499959 - Canbay E, Kurnaz O, Canbay B, et al (2012). PPAR-gamma Pro12Ala polymorphism and gastric cancer risk in a Turkish population. Asian Pac J Cancer Prev, 13, 5875-8. https://doi.org/10.7314/APJCP.2012.13.11.5875
- Chisholm S, Teare E, Davies K, et al (2007). Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005). Euro Surveill, 12, 3-4.
- Eun Cs, Han Ds, Park Jy, et al (2003). Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases. J gastroenterol, 38, 436-441. https://doi.org/10.1007/s00535-002-1079-2
- Frenck Jr, Rw, Clemens J (2003). Helicobacter in the developing world. Microb Infect, 5, 705-13. https://doi.org/10.1016/S1286-4579(03)00112-6
- Gerrits Mm, Van Vliet Ah, Kuipers Ej, et al (2006). Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infectious Diseases, 6, 699-709. https://doi.org/10.1016/S1473-3099(06)70627-2
- Goto Y, Hagikura S, Katsuda N, et al (2011). AC to T polymorphism of urokinase plasminogen activator (P141L) is associated with Helicobacter pylori infection. Asian Pac J Cancer Prev, 12, 803-6.
- Greene M, Blumberg B, Mcbride O, et al (1994). Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene expression, 4, 281-99.
-
He W (2009). PPAR
${\gamma}$ 2Pro12Ala polymorphism and human health. PPAR research, 1-15. - Jing Ym, Guo Sx, Zhang Xp, et al (2012). Association between C1019T polymorphism in the connexin 37 gene and Helicobacter pylori infection in patients with gastric cancer. Asian Pac J Cancer Prev, 13, 2363-7. https://doi.org/10.7314/APJCP.2012.13.5.2363
- Kim Jj, Reddy R, Lee M, et al (2001). Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemot, 47, 459-61. https://doi.org/10.1093/jac/47.4.459
- Konturek Pc, Kania J, Kukharsky V, et al (2004). Implication of peroxisome proliferator-activated receptor. GAMMA. and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection. J Pharmacol Sci, 96, 134-43. https://doi.org/10.1254/jphs.FPJ04016X
- Liao S, Zeng Z, Leung W, et al (2006). Peroxisome proliferatoractivated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese. Aliment Pharmacol Therap, 23, 289-94. https://doi.org/10.1111/j.1365-2036.2006.02739.x
- Ling T, Leung W, Lee C, et al (2002). The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter, 7, 327-8. https://doi.org/10.1046/j.1523-5378.2002.00101_1.x
- Mansour B, Burucoa C, Zribi M, et al (2010). Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrobials, 9, 22. https://doi.org/10.1186/1476-0711-9-22
- Marshall Bj, Armstrong J, Francis G, et al (1987). Antibacterial action of bismuth in relation to campylobacter pyloridis colonization and gastritis. Digestion, 37, 16-30. https://doi.org/10.1159/000199555
- Megraud F, Coenen S, Versporten A, et al (2013). Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut, 62, 34-42. https://doi.org/10.1136/gutjnl-2012-302254
- Michalik L, Desvergne B, Wahli W, et al (2004). Peroxisomeproliferator-activated receptors and cancers: complex stories. Nat Rev Cancer, 4, 61-70. https://doi.org/10.1038/nrc1254
- Parsonnet j, friedman gd, vandersteen DP, et al (1991). Helicobacter pylori infection and the risk of gastric carcinoma. New England J Med, 325, 1127-31. https://doi.org/10.1056/NEJM199110173251603
- Prasad K, Saxena A, Ghoshal U, et al (2008). Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease. Ann Oncol, 19, 1299-303. https://doi.org/10.1093/annonc/mdn055
-
Shibata T, Tahara T, Yonemura J, et al (2010). The G-protein
${\beta}$ 3 polymorphism is associated with diffuse type gastric cancer in Japanese. Asian Pac J Cancer Prev, 11, 1195-9. -
Tahara T, Arisawa T, Shibata T, et al (2008). Influence of peroxisome proliferator-activated receptor (PPAR)
${\gamma}$ Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. Digestive Dis Sci, 53, 614-21. https://doi.org/10.1007/s10620-007-9944-8 - Tomatari Fh, Mobarez Am, Amini M, et al (2010). Helicobacter pylori resistance to metronidazole and clarithromycin in dyspeptic patients in Iran. Iranian Red Crescent Med J, 12, 409-12.
- Torres J, Camorlinga-Ponce M, Perez-Perez G, et al (2001). Increasing multidrug resistance in Helicobacter pylori Strains isolated from children and adults in Mexico. J Clin Microb, 39, 2677-80. https://doi.org/10.1128/JCM.39.7.2677-2680.2001
- Uemura N, Okamoto S, Yamamoto S, et al (2001). Helicobacter pylori infection and the development of gastric cancer. New Eng J Med, 345, 784-9. https://doi.org/10.1056/NEJMoa001999
- Van Amsterdam K, Bart A, Van Der Ende A (2005). A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Ch, 49, 1477-82. https://doi.org/10.1128/AAC.49.4.1477-1482.2005
- Van Doorn Lj, Glupczynski Y, Kusters Jg, et al (2001). Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Ch, 45, 1500-4. https://doi.org/10.1128/AAC.45.5.1500-1504.2001
- Vilaichone Rk, Panarat W, Aekpongpaisit S, et al (2014). Clinical characteristics and Helicobacter pylori status of gastric cancer in Thailand. Asian Pac J Cancer Prev, 15, 9005. https://doi.org/10.7314/APJCP.2014.15.20.9005
- Wheeldon T, Granstrom M, Hoang T, et al (2004). The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Aliment Pharm Therap, 19, 1315-21. https://doi.org/10.1111/j.1365-2036.2004.01959.x